Reunion Neuroscience Inc (REUN)

[John Smith Kalk]

People are talking about psychedelic treatments and therapies and how it can help treat mental disorders and addictions. Many small biotechnology and pharmaceutical firms are also entering the market with the growing importance of mental health. There are two new psychedelic stocks that are trending nowadays and are in hot news- Numinus Wellness (TSX: NUMI) and Field Trip Health (TSX: FTRP). Numinus Wellness agreed to acquire Novamind (CSE: NM), a Toronto-based psychedelic firm, for an all-in share transaction. Numinus expects that this acquisition will bolster its financial performance by increasing its annual revenue and improving its margin through identified operating efficiencies whereas Field Trip Health (TSX: FTRP) was recently granted US Patent for FT-104, its first novel psychedelic molecule in development, and gained exclusive rights to its composition and protection until 2040. The psychedelic company earned C$ 1.36 million in patient services revenue in Q3 FY2021 compared to C$ 0.31 million a year ago.